Sound waves vs. pancreatic cancer: new device tested in humans

NCT ID NCT06282809

First seen Jun 27, 2026 · Last updated Jul 10, 2026 · Updated 2 times

Summary

This study tests a device called the HistoSonics Edison System, which uses focused sound waves (histotripsy) to mechanically break apart pancreatic tumors without surgery. The trial will enroll 50 adults with advanced pancreatic cancer that cannot be removed surgically. The main goal is to see if the procedure is safe, measuring any complications within 30 days.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
HistoSonics Edison System (focused ultrasound device)
What this could lead to
If successful, this could offer a new, non-invasive way to destroy pancreatic tumors without surgery, potentially improving outcomes for patients with advanced disease.
What could go wrong
This is an early safety trial with only 50 participants, so it may not prove effective. The procedure could cause complications like bleeding or infection, and it is not a cure.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADENOCARCINOMA OF THE PANCREAS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Hospital de la Santa Creu i Sant Pau

    RECRUITING

    Barcelona, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.